MOLECULAR BASIS OF IMMUNOGLOBULIN HEAVY CHAIN SWITCH
免疫球蛋白重链开关的分子基础
基本信息
- 批准号:3135187
- 负责人:
- 金额:$ 24.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-08-01 至 1989-07-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte endonuclease endoribonucleases gene complementation gene expression genetic manipulation genetic mapping hybridomas immunofluorescence technique immunogenetics immunoglobulin G immunoglobulin M immunoglobulin genes immunoglobulins immunoregulation lymphoma molecular cloning molecular oncology nucleic acid sequence tissue /cell culture
项目摘要
The murine B cell lymphoma, I.29, consists of cells expressing either IgM
or IgA with the identical idiotype and with the identical heavy (H) chain
variable (V) region sequence. By DNA blotting experiments and by
examination of cloned H chain genes, we found that the IgM cells contain
one expressed VDJ-CMu gene and one non-expressed DJ-CMu gene segment, and
all the other H chain C genes in the germline configuration. The IgA cells
have deleted Mu genes from both chromosomes, and have undergone a typical
switch recombination with the Alpha gene on the expressed chromosomes, and
the Gamma3 gene on the non-expressed chromosome.
When purified IgM cells from the tumor are cultured in vitro they can be
induced to switch to IgA or to IgE with LPS or with monoclonal anti-IgM or
anti-I.29 idiotype (Id). We propose to clone T cells which will help the
switch to either IgA or to IgE. We plan to clone DNA fragments bearing the
rearranged Alpha and Mu genes about 3 days after induction of switching to
examine the earliest DNA recombination events, to determine whether
specific sites are involved and whether sister-chromatid exchange may occur.
The IgM cells appear to be committed to switch to either IgA or IgE, as the
Alphagene is hypomethylated (relative to liver DNA) in the IgM cells,
whereas the Gamma2b gene is not. Furthermore, the Alpha and Epsilon genes
are being transcribed at a low level in the IgM cells, whereas the Gamma1
and Gamma2b genes are not. We will further examine the mechanism of
predetermination of isotype specificity by studies of chromatin structure
and by attempting to induce isotype switching in hybrids of the B cell
lymphoma, WEHI 279, and I.29Mu cells. The DNA sequences required for
isotype switching and the specificity of switching will be studied by
transfection of Ig H chain gene constructs which can serve as substrates
for switch recombination into I.29Mu cells, which will then be induced to
switch. Eventually we will attempt to prepare a cell-free system which can
recombine switch region sequences. Our plans also include the cloning of
cDNAs for poly(A)+ RNAs which appear when switching is induced. We will
attempt to determine what proteins these genes encode.
鼠B细胞淋巴瘤I. 29由表达IgM或IgM的细胞组成。
或具有相同独特型和相同重(H)链的伊加
可变(V)区序列。 通过DNA印迹实验和
对克隆的H链基因进行检测,我们发现IgM细胞含有
一个表达的VDJ-CMu基因和一个非表达的DJ-CMu基因片段,和
所有其他的H链C基因在生殖系的配置。 伊加细胞
从两条染色体上删除了Mu基因,并经历了一个典型的
与表达染色体上的Alpha基因进行切换重组,以及
非表达染色体上的Gamma 3基因。
当在体外培养来自肿瘤的纯化的IgM细胞时,它们可以是
用LPS或单克隆抗IgM诱导转换为伊加或IgE,或
抗I.29独特型(Id)。 我们建议克隆T细胞,这将有助于
换用伊加或IgE 我们计划克隆带有
诱导转换后约3天,
检查最早的DNA重组事件,以确定是否
是否涉及特定位点以及是否可能发生姐妹染色单体交换。
IgM细胞似乎致力于转换为伊加或IgE,因为IgM细胞可能是IgA细胞。
Alphagene在IgM细胞中是低甲基化的(相对于肝脏DNA),
而Gamma 2b基因不是。 此外,阿尔法和Epoxy基因
在IgM细胞中以低水平转录,而γ 1
而Gamma 2b基因则不是。 我们会进一步研究
通过染色质结构研究预先确定同种型特异性
并通过尝试诱导B细胞杂交体中的同种型转换
淋巴瘤、WEHI 279和I.29Mu细胞。 所需的DNA序列
同种型转换和转换的特异性将通过
可作为底物的IG H链基因构建体的转染
用于开关重组到I.29Mu细胞中,然后将诱导I.29Mu细胞
开关. 最终我们将尝试制备一种无细胞系统,
重组开关区序列。 我们的计划还包括克隆
当诱导转换时出现的poly(A)+RNA的cDNA。 我们将
试图确定这些基因编码的蛋白质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Janet M. Stavnezer其他文献
Janet M. Stavnezer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Janet M. Stavnezer', 18)}}的其他基金
Function of the AID C terminus in Ig class switching
AID C 末端在 Ig 类别转换中的功能
- 批准号:
8292343 - 财政年份:2012
- 资助金额:
$ 24.31万 - 项目类别:
Molecular Basis of Immunoglobulin Heavy Chain Switch
免疫球蛋白重链开关的分子基础
- 批准号:
8090512 - 财政年份:2010
- 资助金额:
$ 24.31万 - 项目类别:
c-myc DNA breaks and c-myc-IgH locus translocations: roles of AID and oxidation
c-myc DNA 断裂和 c-myc-IgH 基因座易位:AID 和氧化的作用
- 批准号:
7865093 - 财政年份:2010
- 资助金额:
$ 24.31万 - 项目类别:
c-myc DNA breaks and c-myc-IgH locus translocations: roles of AID and oxidation
c-myc DNA 断裂和 c-myc-IgH 基因座易位:AID 和氧化的作用
- 批准号:
8097530 - 财政年份:2010
- 资助金额:
$ 24.31万 - 项目类别:
Molecular Basis of Immunoglobulin Heavy Chain Switch
免疫球蛋白重链开关的分子基础
- 批准号:
7846563 - 财政年份:2009
- 资助金额:
$ 24.31万 - 项目类别:
Isotype specific regulation of lg class switching
LG 类别转换的同种型特异性调节
- 批准号:
7140383 - 财政年份:2005
- 资助金额:
$ 24.31万 - 项目类别:
Isotype specific regulation of lg class switching
LG 类别转换的同种型特异性调节
- 批准号:
6965565 - 财政年份:2005
- 资助金额:
$ 24.31万 - 项目类别:
相似海外基金
Preclinical evaluation of a homing endonuclease gene therapy for adRP in models of P23H retinopathy.
P23H 视网膜病变模型中 adRP 归巢核酸内切酶基因疗法的临床前评估。
- 批准号:
10587797 - 财政年份:2023
- 资助金额:
$ 24.31万 - 项目类别:
Investigating the use of a novel Dualase (dual-endonuclease) system in repairing nonsense mutations and restoring CFTR expression in cystic fibrosis mouse and human airway models
研究使用新型 Dualase(双核酸内切酶)系统修复囊性纤维化小鼠和人类气道模型中的无义突变并恢复 CFTR 表达
- 批准号:
486584 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
Studentship Programs
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination
阐明 RAG 核酸内切酶介导的 V(D)J 重组反馈抑制机制
- 批准号:
10538891 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
- 批准号:
10683329 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination
阐明 RAG 核酸内切酶介导的 V(D)J 重组反馈抑制机制
- 批准号:
10664014 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
- 批准号:
10481430 - 财政年份:2022
- 资助金额:
$ 24.31万 - 项目类别:
Repurposing Endonuclease V for the detection and engineering of adenosine-to-inosine editing
重新利用核酸内切酶 V 进行腺苷至肌苷编辑的检测和改造
- 批准号:
10729813 - 财政年份:2021
- 资助金额:
$ 24.31万 - 项目类别:
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy
FEN1 核酸内切酶作为癌症治疗的合成致死靶点
- 批准号:
10467002 - 财政年份:2021
- 资助金额:
$ 24.31万 - 项目类别:
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy
FEN1 核酸内切酶作为癌症治疗的合成致死靶点
- 批准号:
10294863 - 财政年份:2021
- 资助金额:
$ 24.31万 - 项目类别:
Repurposing Endonuclease V for the detection and engineering of adenosine-to-inosine editing
重新利用核酸内切酶 V 进行腺苷至肌苷编辑的检测和改造
- 批准号:
10322142 - 财政年份:2021
- 资助金额:
$ 24.31万 - 项目类别: